Low health-related quality of life is associated with all-cause mortality in patients with diabetes on haemodialysis: The Japan Dialysis Outcomes and Practice Pattern Study

Diabetic Medicine

Volumn 26, Issue 9, 2009, Pages 921-927

  Hayashino, Y ^a   Fukuhara, S ^a   Akiba, T ^b   Akizawa, T ^c   Asano, Y ^d   Saito, S ^e   Kurokawa, K ^f  

^a KYOTO UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Mito Red Cross Hospital   (Japan)

^e TOKAI UNIVERSITY   (Japan)

^f NATIONAL GRADUATE INSTITUTE FOR POLICY STUDIES   (Japan)

Author keywords

Diabetes; Haemodialysis; Health related quality of life; Mortality

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; BODY MASS; COMORBIDITY; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; HYPERTENSION; JAPAN; KAPLAN MEIER METHOD; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIPHERAL VASCULAR DISEASE; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; RISK FACTOR; SHORT FORM 36; STATISTICAL ANALYSIS; TREATMENT DURATION;

DIABETIC NEPHROPATHIES; FEMALE; HUMANS; JAPAN; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 69249173085     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2009.02800.x     Document Type: Article

References (21)

1. CDC. Number of Persons with Diagnosed Diabetes, United States, 1980-2002. Atlanta, Georgia : Centers for Disease Control and Prevention, 2004.
2. Kawakami F, Ito M, Matsuda Y, Hayashi I, Ohtsuki K. The effects of cholesterol-3-sulfate (CH-3S) on the phosphorylation of human C3a (hC3a) in vitro and on the ability of hC3a to induce vascular permeability in rats. Biol Pharm Bull 2004 27 : 282 287.
3. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 years before clinical diagnosis. Diabetes Care 1992 15 : 815 819.
4. Ettaro L, Songer TJ, Zhang P, Engelgau MM. Cost-of-illness studies in diabetes mellitus. Pharmacoeconomics 2004 22 : 149 164.
5. Council on Medical Service Facilities. Medical Economics Survey 2003. Available at http://www.mhlw.go.jp/topics/2003/06/tp0627-3.html Last accessed 23 July 2009 (in Japanese).
6. ADA. Type 2 Diabetes Complications. American Diabetes Association, 2004. Available at http://www.diabetes.org/type-2-diabetes/complications.jsp Last accessed 23 July 2009.
7. Rubin RR, Peyrot M. Quality of life and diabetes. Diabetes Metab Res Rev 1999 15 : 205 218.
8. Lee SJ, Lindquist K, Segal MR, Covinsky KE. Development and validation of a prognostic index for 4-year mortality in older adults. J Am Med Assoc 2006 295 : 801 808.
9. Kleefstra N, Landman GW, Houweling ST, Ubink-Veltmaat LJ, Logtenberg SJ, Meyboom-de Jong B et al. Prediction of mortality in type 2 diabetes from health-related quality of life (ZODIAC-4). Diabetes Care 2008 31 : 932 933.
10. Young EW, Goodkin WA, Mapes DL, Port FK, Keen ML, Chen K et al. The Dialysis Outcomes and Practice Patterns Study (DOPPS): an international hemodialysis study. Kidney Int 2000 57 : S74 S81.
11. Hayashino Y, Fukuhara S, Akiba T, Akizawa T, Asano Y, Saito A et al. Diabetes, glycaemic control and mortality risk in patients on haemodialysis: the Japan Dialysis Outcomes and Practice Pattern Study. Diabetologia 2007 50 : 1170 1177. (Pubitemid 46701557)
12. Greenfield S, Rogers W, Mangotich M, Carney MF, Tarlov AR. Outcomes of patients with hypertension and non-insulin dependent diabetes mellitus treated by different systems and specialties. Results from the medical outcomes study. J Am Med Assoc 1995 274 : 1436 1444.
13. Jenkinson C, Lawrence K, McWhinnie D, Gordon J. Sensitivity to change of health status measures in a randomized controlled trial: comparison of the COOP charts and the SF-36. Qual Life Res 1995 4 : 47 52.
14. Brazier JE, Harper R, Jones NM, O'Cathain A, Thomas KJ, Usherwood T et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. Br Med J 1992 305 : 160 164.
15. Garratt AM, Ruta DA, Abdalla MI, Buckingham JK, Russell IT. The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? Br Med J 1993 306 : 1440 1444.
16. Lyons RA, Lo SV, Littlepage BN. Comparative health status of patients with 11 common illnesses in Wales. J Epidemiol Community Health 1994 48 : 388 390.
17. Bullinger M. German translation and psychometric testing of the SF-36 Health Survey: preliminary results from the IQOLA Project. International Quality of Life Assessment. Soc Sci Med 1995 41 : 1359 1366.
18. Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K. Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. J Clin Epidemiol 1998 51 : 1037 1044.
19. Rumsfeld JS, MaWhinney S, McCarthy M Jr., Shroyer AL, VillaNueva CB, O'Brien M et al. Health-related quality of life as a predictor of mortality following coronary artery bypass graft surgery. Participants of the Department of Veterans Affairs Cooperative Study Group on Processes, Structures, and Outcomes of Care in Cardiac Surgery. J Am Med Assoc 1999 281 : 1298 1303.
20. Mapes DL, Lopes AA, Satayathum S, McCullough KP, Goodkin DA, Locatelli F et al. Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 2003 64 : 339 349.
21. Kazis LE. Health Status of Veterans: Physical and Mental Component Summary Scores (SF-36V). National Survey of Ambulatory Care Patients Executive Report. Washington, DC : VA Headquarters, Center for Health Quality Outcomes and Economic Research, 1996.